Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P070008/S177

BIOexpress

Biotronik, Inc. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONP070008/S177

What did the FDA approve?

The FDA record shows approval of supplement P070008/S177 for BIOexpress, filed by Biotronik, Inc. under the normal 180-day track. The stated reason is a change to design, components, specifications or material. The approved statement describes BIOexpress as a dedicated interrogation-only device for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs).

The S177 designation ties this action to the original P070008 approval, but a supplement is not a new approval of the whole system. The record does not specify what the changed design item is beyond the general category, and the statement's purpose language does not by itself establish safety or clinical effectiveness. One detail is absent: the record does not identify which BIOexpress component or specification changed.

The device category listed is a pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P), product code NKE, cardiovascular specialty.

FDA approval order statement

BIOexpress, a dedicated interrogation-only device for status checks of BIOTRONIK implantable pulse generators (IPGs, CRT-Ps), implantable cardioverter defibrillators (ICDs, CRT-Ds) and implantable cardiac monitors (ICMs)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P070008/S177
Regulatory pathway
PMA supplement
Product code
NKE
Decision code
APPR
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P).

Product code
NKE
FDA device class
3

For the original device and its historical approval scope, see PMA P070008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P070008 · Original PMA

    STRATOS LV CRT-P AND STRATOS LV-T CRT-P, COROX OTW BP LEAD AND COROX OTW-S BP LEAD

  2. P070008/S177 received

    Application receipt date recorded by FDA.

  3. P070008/S172 · Related supplement

    Edora 8 HF-T QP 407137 Edora 8 HF-T 407138 Evity 8 HF-T QP 407139 Evity 8 HF-T 407140 Enitra 8 HF-T QP 407141 Enitra 8 H

  4. P070008/S182 · Related supplement

    Edora 8 HF-T QP Edora 8 HF-T Evity 8 HF-T QP Evity 8 HF-T Enitra 8 HF-T QP Enitra 8 HF-T Enticos 8 HF-T QP Enticos 8 HF-

  5. P070008/S181 · Related supplement

    Edora 8 HF-T QP 407137; Edora 8 HF-T 407138; Evity 8 HF-T QP 407139; Evity 8 HF-T 407140; Enitra 8 HF-T QP 407141; Enitr

  6. P070008/S183 · Related supplement

    Edora 8 HF-T QP, Edora 8 HF-T, Evity 8 HF-T QP, Evity 8 HF-T, Enitra 8 HF-T QP, Enitra 8 HF-T

  7. P070008/S177 · FDA decision

    Normal 180 Day Track

  8. P070008/S184 · Related supplement

    Sentus ProMRI OTW QP S-75, Sentus ProMRI OTW QP S-85, Sentus ProMRI OTW QP S-95, Sentus ProMRI OTW QP L-75, Sentus ProMR

Timeline entries are records held by MedtechLedger for P070008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070008

Explore the linked device profile

Other records with product code NKE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records